Why Larger Healthcare Companies Attract a Different Class of Buyers
Why Larger Healthcare Companies Attract a Different Class of Buyers Key Takeaways Introduction — The Strategic Value of Scale In today’s market, healthcare consolidation isn’t just about size — it’s about strategic sophistication. Larger healthcare companies attract a different class of buyers because they offer predictable performance, diversified payers, and institutional elements that mitigate risk […]
Read More
The Risk Discount: Why Buyers Pay Less for Unclear Healthcare Operations
The Risk Discount: Why Buyers Pay Less for Unclear Healthcare Operations Key Takeaways What Is the Risk Discount in Healthcare Deals How Buyers Translate Uncertainty Into Lower Pricing In healthcare transactions, the “risk discount” refers to the reduction in valuation buyers apply when a business lacks clarity. Even profitable practices can lose value if operations […]
Read More
How to Avoid the Most Common Healthcare Company CEO Mistakes During Healthcare Exits
How to Avoid the Most Common Healthcare Company CEO Mistakes During Healthcare Exits Key Takeaways Why Strong Companies Still Slip Even strong providers can struggle in a sale when the story is harder to underwrite than the business is to admire. In 2026, buyers are still active, but they favor quality assets with clean cash […]
Read More
How to Negotiate Healthcare Company Earnouts Without Handcuffing Your Future
How to Negotiate Healthcare Company Earnouts Without Handcuffing Your Future Key Takeaways Why Earnouts Show Up Earnouts still appear in healthcare transactions because they help buyers and sellers close valuation gaps when future performance feels uncertain. As MedBridge explains in What Healthcare Agencies Do When Buyers Ask for Aggressive Earnouts, contingent payments often look like […]
Read More
How to Negotiate Healthcare Company Working Capital and Net Debt Like a Pro
How to Negotiate Healthcare Company Working Capital and Net Debt Like a Pro Key Takeaways Why Price Changes at Closing Many healthcare owners focus on headline valuation, but real proceeds often move later. Items like working capital, net debt, and closing adjustments can quietly reshape value. Sellers who study purchase price mechanics before exclusivity usually […]
Read More
A Healthcare CEO’s “Deal Structure Menu”: Asset Sale vs Stock Sale vs Merger
A Healthcare CEO’s “Deal Structure Menu”: Asset Sale vs Stock Sale vs Merger Key Takeaways Why Deal Structure Matters Many healthcare CEOs focus first on valuation, but structure often has a bigger impact on the final result. Taxes, liabilities, indemnities, and working-capital adjustments can all change what the seller actually receives. That is why early […]
Read More
What Healthcare CEOs Should Ask About a Healthcare Advisor’s Buyer Relationships (And Proof)
What Healthcare CEOs Should Ask About a Healthcare Advisor’s Buyer Relationships (And Proof) Key Takeaways Why Buyer Relationships Determine Valuation, Speed, and Deal Certainty In healthcare M&A, outcomes are rarely accidental. Valuation strength, timeline efficiency, and closing certainty are directly influenced by the depth of an advisor’s buyer relationships. According to Bain & Company’s Global […]
Read More
How to Sell a Healthcare Company When Interest Rates Make Buyers More Cautious
How to Sell a Healthcare Company When Interest Rates Make Buyers More Cautious Key Takeaways Why Rising Interest Rates Change the Rules of Healthcare M&A For more than a decade, low-cost capital fueled aggressive acquisition activity in healthcare. Private equity firms deployed record amounts of capital into physician groups, dental platforms, behavioral health operators, and […]
Read More
How Healthcare Business Brokers Evaluate Referral Concentration and Its Impact on Price
How Healthcare Business Brokers Evaluate Referral Concentration and Its Impact on Price Key Takeaways Introduction When healthcare practice owners think about valuation, they usually focus on EBITDA, growth rate, and payer mix. But there’s another powerful variable quietly influencing deal price: referral concentration. In healthcare transactions, predictability equals value. Buyers — especially private equity groups, […]
Read More
What Healthcare CEOs Should Know About IOIs, LOIs, and “Soft Commitments”
What Healthcare CEOs Should Know About IOIs, LOIs, and “Soft Commitments” Key Takeaways Understanding the Basics: IOIs, LOIs, and Soft Commitments in Healthcare M&A Navigating a healthcare merger or acquisition can feel like walking a tightrope, especially when multiple offers are on the table. For CEOs of medical or dental practices, the process often begins […]
Read More